Bender Robert & Associates’s Evolus EOLS Stock Holding History

Bender Robert & Associates’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$201K	Buy	+25,070	New	+$188K	0.04%	44
2026 Q2	–	Sell	-25,070	Closed	-$103K	–	42
2026 Q1	$103K	Buy	+25,070	New	+$121K	0.02%	45
2025 Q4	–	Sell	-25,070	Closed	-$154K	–	42
2025 Q3	$154K	Hold	25,070	–	–	0.03%	46
2025 Q2	$231K	Buy	+25,070	New	+$257K	0.05%	40
2025 Q1	–	Sell	-25,070	Closed	-$277K	–	43
2024 Q4	$277K	Buy	+25,070	New	+$353K	0.07%	40
2024 Q1	–	Sell	-25,070	Closed	-$264K	–	46
2023 Q4	$264K	Hold	25,070	–	–	0.07%	42
2023 Q3	$229K	Hold	25,070	–	–	0.07%	44
2023 Q2	$182K	Hold	25,070	–	–	0.05%	47
2023 Q1	$212K	Buy	+25,070	New	+$227K	0.07%	51
2022 Q4	–	Sell	-25,070	Closed	-$202K	–	50
2022 Q3	$202K	Hold	25,070	–	–	0.08%	48
2022 Q2	$291K	Buy	+25,070	New	+$296K	0.11%	44
2021 Q2	–	Sell	-25,000	Closed	-$325K	–	48
2021 Q1	$325K	Buy	+25,000	New	+$230K	0.1%	48

Other funds holding EOLS

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Angeles Wealth Management Santa Monica, California $2.27B AUM 17.57% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Chicago Partners Investment Group Chicago, Illinois $5.45B AUM 19.52% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return

Bender Robert & Associates's EOLS Position: Q3 2026 in Review

Bender Robert & Associates opened a new position in Evolus (EOLS) in Q3 2026: 25,070 shares worth $201K. The stake represents 0.04% of the portfolio and ranks #44 among its holdings. This is a return to the name: Bender Robert & Associates previously reported a position in EOLS as recently as Q1 2026.

Bender Robert & Associates first reported a position in EOLS in Q1 2021 and has held it in 12 quarters since. The position peaked at $325K in Q1 2021. 32 funds tracked by Wall St. Rank hold EOLS as of Q3 2026.

Bender Robert & Associates held 25,070 shares of Evolus worth $201K as of Q3 2026.
Evolus was a new Bender Robert & Associates position in Q3 2026.
Evolus made up 0.04% of Bender Robert & Associates's portfolio in Q3 2026, its #44 holding.
Bender Robert & Associates first reported a position in Evolus in Q1 2021 and has held it in 12 quarters since.
Bender Robert & Associates's Evolus position peaked at $325K in Q1 2021.
32 funds tracked by Wall St. Rank held Evolus as of Q3 2026.

Based on Bender Robert & Associates's 13F filing for Q3 2026, filed 21 Oct 2026.